The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 production
Jun Shimizu(Kyoto University), Tatsuo Shioda(The University of Osaka), Yuka Yoshimura, Tadahiro Sasaki(The University of Osaka), Yoko Ichihara, Pedro E. Cruz, Kiyoe Itoi, Ritsuko Koketsu(The University of Osaka), Naomi Tanga, Atsushi Yamanaka(The University of Osaka), Yoshihiro Samune(Ekaterinburg Research Institute of Viral Infections), Ami Murakami, Misuzu Yamada, Kei Sato(University of Tokyo Hospital), Emi E. Nakayama(The University of Osaka), Kazuo Miyazaki(Quantum Chemistry Research Institute)
Cited by 25
Related Papers
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene
|Nature|1991|522
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
|Cell Reports|2020|438
<b>Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense</b>
|Genes to Cells|1996|231
IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
|Journal of the American Society of Nephrology|2005|154